Pfizer sells bigger-than-expected stake in Haleon
Haleon
334.40p
16:35 26/04/24
0.87%
2.90p
Haleon said on Tuesday that Pfizer has sold a larger-than-expected stake in the consumer healthcare group, taking its interest down to 22.6% from 32%.
FTSE 100
8,139.83
17:09 26/04/24
n/a
n/a
FTSE 350
4,470.09
16:59 26/04/24
n/a
n/a
FTSE All-Share
4,423.59
17:14 26/04/24
n/a
n/a
Pfizer Inc.
$25.40
11:04 26/04/24
0.55%
$0.14
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
0.10%
22.78
Pfizer was planning to sell around 630m shares in a public offering but the size of the offering was increased to just over 790.5m.
Haleon sold 594m ordinary shares at £3.08 each and 196.5m American Depository Shares (ADR) at $7.85 each. It raised around £1.8bn and $1.5bn, respectively.
The maker of Sensodyne toothpaste and Panadol said it has also agreed to buy back 102.2m ordinary shares from Pfizer off-market for around £315m.